Erythema Multiforme: Recognition and Management.
Trayes KP, Love G, Studdiford JS.
Am Fam Physician. 2019 Jul 15;100(2):82-88.
Mycoplasma pneumoniae-induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme: a systematic review.
Canavan TN, Mathes EF, Frieden I, Shinkai K.
J Am Acad Dermatol. 2015 Feb;72(2):239-45. doi: 10.1016/j.jaad.2014.06.026.
Erythema multiforme, Stevens-Johnson syndrome/toxic epidermal necrolysis - diagnosis and treatment.
Grünwald P, Mockenhaupt M, Panzer R, Emmert S.
J Dtsch Dermatol Ges. 2020 Jun;18(6):547-553. doi: 10.1111/ddg.14118. Epub 2020 May 29.
Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis.
Hasegawa A, Abe R.
F1000Res. 2020 Jun 16;9:F1000 Faculty Rev-612. doi: 10.12688/f1000research.24748.1. eCollection 2020.
Drug Hypersensitivity Reactions.
Wilkerson RG.
Immunol Allergy Clin North Am. 2023 Aug;43(3):473-489. doi: 10.1016/j.iac.2022.10.005.
Radiodermatitis: A Review of Our Current Understanding.
Singh M, Alavi A, Wong R, Akita S.
Am J Clin Dermatol. 2016 Jun;17(3):277-92. doi: 10.1007/s40257-016-0186-4.
Stevens-Johnson syndrome in children.
Ramien ML.
Curr Opin Pediatr. 2022 Aug 1;34(4):341-348. doi: 10.1097/MOP.0000000000001146.
Severe erythema multiforme.
SNEDDON IB.
Br Med J. 1947 Jun 28;1(4512):925-7. doi: 10.1136/bmj.1.4512.925.
Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.
Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC.
Arch Dermatol. 1993 Jan;129(1):92-6.
Pediatric SJS-TEN: Where are we now?
Ramien M, Goldman JL.
F1000Res. 2020 Aug 13;9:F1000 Faculty Rev-982. doi: 10.12688/f1000research.20419.1. eCollection 2020.
